CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
about
Pancreatic cancer stem cell markers and exosomes - the incentive pushNew Insights into the Crossroads between EMT and Stemness in the Context of CancerThe effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patientsThe role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulationSensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells.Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical ImplicationsCD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer.Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma.Tumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2.The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis.The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancerDo Cancer Cell Lines Have Fixed or Fluctuating Stem Cell Phenotypes? - Studies with the NTera2 Cell Line.Effect of MUC1/β-catenin interaction on the tumorigenic capacity of pancreatic CD133(+) cells.CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells.Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition.Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.Concise Review: Pancreatic Cancer and Bone Marrow-Derived Stem Cells.Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma."Heat shock protein 70 in pancreatic diseases: Friend or foe".Expression levels of SOX2, KLF4 and brachyury transcription factors are associated with metastasis and poor prognosis in oral squamous cell carcinoma.The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level.Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133+ tumor initiating cells.TNFα and TGFβ-1 synergistically increase the cancer stem cell properties of MiaPaCa-2 cells."Nutrient-sensing" and self-renewal: O-GlcNAc in a new role.NFκB-Mediated Invasiveness in CD133+ Pancreatic TICs Is Regulated by Autocrine and Paracrine Activation of IL1 Signaling.Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche.Fractional uptake of circulating tumor cells into liver-lung compartments during curative resection of periampullary cancerTransforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
P2860
Q26741215-7F3E1802-FE2A-4CF1-B441-77436F0801F5Q26764831-A12F91D2-F2D4-4EFB-BBE8-3E46556FAFC5Q33885293-E5508F3D-7E79-49ED-BC45-27FD1CA9B48BQ33907274-8AD91377-4860-4791-A0DC-9A08C882EE1BQ36116632-1510D501-642B-40DB-906B-9ED3414167EEQ36134298-F89FC5AD-1AF9-4693-9495-23F82A98A44CQ36406924-4E97B5E1-39A5-47DB-9CB5-0233DBE4429AQ36425752-8FDF9E22-5B28-4193-B48F-A99A6C995B85Q37190973-6B4DD21A-0013-4B65-AE43-C655D69CE09DQ37636662-92CF016B-8D26-471D-B045-F975C22CA773Q37673528-78F82166-02E6-4FB7-9834-FA72852F39B4Q38699976-3D5355F1-6ED4-40E5-B63E-A00EF453E32AQ38747818-36B7BDD8-FA84-4689-A2E9-04BEC27F6A6FQ38760452-235D337B-6A1D-4F07-853C-35D646FB36D1Q38799932-71B3F72D-322D-4E33-B7A2-D8530E7D492EQ38817435-EFF41F60-5317-4FE7-8CAA-2BDFC90A06CBQ38842731-DA69AEB9-4CEE-497F-9B9B-50EAC97E0556Q39108676-7AD8F11E-C69C-4B8A-AEF9-710E70CC0FF0Q39329712-4EA0C66F-BC4C-4EF8-BBB2-B8D2BD2DB2C1Q40900177-9E2CBB39-D938-4CD2-8106-23867D448609Q41225471-581FEAAB-DF67-452B-9FEC-C4F438C8A17EQ41866335-D3C1B723-E205-4882-B0AB-7C2D9444E22FQ47136188-D37F4376-A42C-486E-A198-2245D965789EQ48182327-036FE48D-2E11-43F5-B9B9-6FF3B8091A85Q50262493-A0E37A15-0AEB-4D12-A272-ADD8E2A2ADE9Q51145791-A9ADD55B-69E4-4D53-9CAE-5C04351825AFQ51516469-A8321ADD-EAD4-4EAB-A9E1-A16CB40DBC14Q55257164-9075281E-4A2D-45B8-B068-2820F22C6560Q58572801-317C443A-2F79-4914-A8B0-343E61DFEB1DQ58754397-6FEDFB6B-5AE4-464C-A9AD-3FBF965570DD
P2860
CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CD133 initiates tumors, induce ...... etastasis in pancreatic cancer
@ast
CD133 initiates tumors, induce ...... etastasis in pancreatic cancer
@en
type
label
CD133 initiates tumors, induce ...... etastasis in pancreatic cancer
@ast
CD133 initiates tumors, induce ...... etastasis in pancreatic cancer
@en
prefLabel
CD133 initiates tumors, induce ...... etastasis in pancreatic cancer
@ast
CD133 initiates tumors, induce ...... etastasis in pancreatic cancer
@en
P2093
P2860
P356
P1433
P1476
CD133 initiates tumors, induce ...... etastasis in pancreatic cancer
@en
P2093
Ashok K Saluja
Masato Yamamoto
Rohit Chugh
Selwyn M Vickers
Sulagna Banerjee
Vikas Dudeja
P2860
P304
P356
10.18632/ONCOTARGET.3228
P407
P50
P577
2015-04-01T00:00:00Z